Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections (Q45706430)

From Wikidata
Jump to navigation Jump to search
scientific article published in December 2003
edit
Language Label Description Also known as
English
Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections
scientific article published in December 2003

    Statements

    Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections (English)
    H Cody Meissner
    Sarah S Long
    American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn
    1 December 2003
    6 Pt 1
    1447-1452

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit